Department of Global Health & Development, The London School of Hygiene & Tropical Medicine, London, United Kingdom

Financial Disclosure: The authors are both at the London School of Hygiene and Tropical Medicine, the sponsor of the Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine trial. Shelley Lees is the lead anthropologist on that trial. Gillian McKay disclosed that money was paid to her institution from: 1) CEPI–funder of the Ebola Vaccine Ad26.ZEBOV, MVA-BN-Filo trial in the DRC–this project is in collaboration with MSF-France, Epicentre, Public Health England, Janssen Vaccines & Prevention, and the DRC Ministry of Health. 2) IMI–funder of the Ebola Ad26.ZEBOV, MVA-BN-Filo trial in West Africa. 3) ELHRA/R2HC. In 2019 Ms. McKay consulted with the IRC on a project in the DRC on sexual and reproductive health in Ebola; she also consulted with WHO in infection prevention and control in Ebola. Gillian has current relationships with UK-Med and the Pierre Elliott Trudeau Foundation. Dr. Shelley Lees disclosed receiving current NIHR funding for anthropological work on vaccines in LMICs.